Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions-Reference-Cited by-同舟云学术

Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions

Published:2011-04-06 Issue:1 Volume:118 Page:4-11
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Zhang Dali,Xiong Wei,Albensi Benedict C.,Parkinson Fiona E.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2011.07242.x/fullpdf

Reference32 articles.

1. C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus;Brust;Neuropharmacology,2007

2. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1;Chen;Behav. Brain Res.,2010

3. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference;Choi;Nat. Neurosci.,2004

4. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors;Cunha;J. Neurosci.,1998

5. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice;Dale;J. Physiol.,2000

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression;Proceedings of the National Academy of Sciences;2024-08-29

2. Deep Brain Stimulation Inhibits Epileptic Seizures via Increase of Adenosine Release and Inhibition of ENT1, CD39, and CD73 Expression;Molecular Neurobiology;2024-07-23

3. Disruption of CD73-Derived and Equilibrative Nucleoside Transporter 1–Mediated Adenosine Signaling Exacerbates Oxygen-Induced Retinopathy;The American Journal of Pathology;2022-11

4. Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer;Cancer Cell International;2022-09-01

5. DRUG TRANSPORT IN THE BRAIN;Drug Transporters;2022-04-05